Table 2.
Treatment group | Summary statistic | ||||
CQ alone | CQ + SP | CQ + SP + PQ0 | CQ + SP + PQ2 | ||
Sample size | 29 | 32 | 28 | 28 | n/a |
Male: Female | 1.2 : 1 | 1.5 : 1 | 1 : 1.2 | 1.3 : 1 | p = 0.771a |
Mean age (range) | 36 (17–55) | 40 (20–60) | 40 (20–62) | 35 (16–65) | p = 0.256b |
Geometric mean asexual parasite density (95% CI) | 653 (382–1118) | 1465 (849–2531) | 1148 (582–2263) | 1409 (720–2760) | p = 0.286b |
Fever Rate | 24% | 41% | 29% | 36% | p = 0.529a |
CQ = chloroquine, SP = sulfadoxine/pyrimethamine, PQ0 = primaquine on day 0, PQ2 = primaquine on day 2, 95% CI = 95% confidence interval
n/a – not applicable
a) Chi-square test
b) Kruskal-Wallis test